PLCG1 and primary cutaneous T-cell non-Hodgkin lymphoma: In the study by Vaqué et al. [60], 21% of 53 patients with CTCL were found to have PLCG1 mutations, and 10 (19%) patients in the entire cohort had the S345F mutation in exon 11, with the other one being the S520F mutation.